PURPOSE: To evaluate the indications and results after penetrating keratoplasty in children at Altino Ventura Foundation (FAV). METHODS: A retrospective study was performed in 33 patients (34 eyes), with ages equal or less than 12 years, they underwent a penetrating keratoplasty at FAV, from 2000 to 2009. The mean follow up time was 32.5 ± 23.1 months. Surgery indication, best corrected visual acuity (BCVA) before and after surgery, spherical equivalent (SE) pos surgical and complications were analyzed. The qualitative results […]

PURPOSE: To evaluate the results of occlusion of the lacrimal punctum reversible with the use of thermosensitive plugs to treat the dysfunctional tear syndrome. METHODS: Eighteen eyes of 9 patients with dry eye were selected and subjected to reversible occlusion of the lacrimal punctum with the use of thermosensitive plugs and were followed for 60 days through the OSDI questionnaire, fluorescein staining, rose bengal staining and Schirmer’s test. RESULTS: in all studied patients there was improvement in dry eye symptoms […]

PURPOSE: The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation. METHODS: Fourteen eyes of 11 patients with multifocal IOL implant associated with vitreous opacities that underwent 25-gauge vitrectomy were prospectively analyzed. Information collected included near (UCNVA) and distance uncorrected visual acuity (UCDVA), best corrected distance visual acuity (BCDVA), and the spherical equivalent (SE) before and 3 months after vitrectomy. Patients […]

Purpose: To evaluate the results of the trabeculotomy-trabeculectomy combined procedure in 12 to 50 years old patients with moderate and advanced glaucoma. Methods: Nineteen eyes of thirteen patients underwent a trabeculotomy-trabeculectomy procedure and were prospectively analyzed and followed up for 21,6 ± 7,2 (5,1 a 29,7) months. Results: IOP was reduced from 32,03 ± 10,01 (12 to 50) mmHg to 9,42 ± 3,50 (2 e 16) mmHg with the number of topical medications being reduced from 1,47 ± 1,54 (0 […]